Literature DB >> 28826283

Radiotherapy and hyperthermia with curative intent in recurrent high risk soft tissue sarcomas.

Franziska Eckert1,2, Lore Helene Braun1, Frank Traub2,3, Hans-Georg Kopp2,4, Bence Sipos2,5, Ulf Lamprecht1, Arndt-Christian Müller1, Frank Paulsen1,2, Daniel Zips1.   

Abstract

PURPOSE: Radiotherapy before or after resection is one of the pillars of treatment for localised high risk soft tissue sarcomas. Treatment intensification has been described with concurrent chemotherapy and hyperthermia. The aim of this study is to assess local control after multimodal treatment, focussing on the treatment of local recurrences after surgery only. PATIENTS AND METHODS: Of 42 patients treated in a prospective protocol with radiotherapy and hyperthermia, nine were treated for isolated local recurrences without metastatic spread. Most patients were treated with trimodal therapy including chemotherapy with ifosfamide and underwent resection whenever possible. Median follow-up was 1.4 years.
RESULTS: The treatment was well tolerated. Estimated disease free survival, distant metastases free survival and local control for the whole cohort after 1.5 years were 66, 73 and 88%, respectively. Neoadjuvant vs. adjuvant treatment influenced local control with a trend to statistical significance. Resection status did not influence local control. The cohort of patients treated for local recurrence after surgery alone had a significantly impaired local control compared to multimodal treatment at primary diagnosis (100 vs. 52%, p < 0.001).
CONCLUSIONS: With multimodal therapy including radiotherapy and hyperthermia local tumour control is achievable even in locally recurrent tumours. The clear-cut difference of the treatment of local recurrence in contrast to primary diagnosis might either reflect difficulties in diagnosis and treatment of local recurrences or biological aggressiveness of recurrent tumours. However, we recommend to consider multimodal treatment at primary diagnosis of high risk soft tissue sarcomas.

Entities:  

Keywords:  Sarcoma; hyperthermia; local control; radiotherapy; recurrence

Mesh:

Year:  2017        PMID: 28826283     DOI: 10.1080/02656736.2017.1369174

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  4 in total

1.  [Locoregional hyperthermia improves disease-specific overall survival in combination with neoadjuvant chemotherapy in high-risk soft tissue sarcomas].

Authors:  Franziska Eckert; Daniel Zips
Journal:  Strahlenther Onkol       Date:  2018-08       Impact factor: 3.621

2.  It's Getting Hot in Here: Targeting Cancer Stem-like Cells with Hyperthermia.

Authors:  Haidong Huang; Kevin Yu; Alireza Mohammadi; Efstathios Karanthanasis; Andrew Godley; Jennifer S Yu
Journal:  J Stem Cell Transplant Biol       Date:  2017-12-29

3.  Hypofractionated preoperative radiotherapy for high risk soft tissue sarcomas in a geriatric patient population.

Authors:  Vlatko Potkrajcic; Frank Traub; Barbara Hermes; Marcus Scharpf; Jonas Kolbenschlag; Daniel Zips; Frank Paulsen; Franziska Eckert
Journal:  Radiol Oncol       Date:  2021-11-19       Impact factor: 2.991

4.  MR Thermometry Data Correlate with Pathological Response for Soft Tissue Sarcoma of the Lower Extremity in a Single Center Analysis of Prospectively Registered Patients.

Authors:  Michaela Unsoeld; Ulf Lamprecht; Frank Traub; Barbara Hermes; Marcus Scharpf; Vlatko Potkrajcic; Daniel Zips; Frank Paulsen; Franziska Eckert
Journal:  Cancers (Basel)       Date:  2020-04-13       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.